Showing posts with label
Recursion
.
Show all posts
Showing posts with label
Recursion
.
Show all posts
Wednesday, July 10, 2024
Two years ago! That was the last time you could buy shares of Recursion Pharmaceuticals (NASDAQ: RXRX) at today's price! Here's why!
›
Recursion Pharmaceuticals (NASDAQ: RXRX) recently raised approximately $200 million through a public offering of 30,769,230 shares of it...
Sunday, May 12, 2024
Recursion Pharmaceuticals is at the forefront of AI-driven drug discovery!
›
Recursion Pharmaceuticals has caught the attention of major pharmaceutical companies due to its innovative approach to drug discovery. Mo...
›
Home
View web version
